CICLOPIROX OLAMINE

CICLOPIROX OLAMINE was reported 476 times

CICLOPIROX OLAMINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADMINISTRATION SITE DERMATITIS 2 0.3333
1 PRIDE SYNDROME 6 0.3158
2 URINARY MEATITIS 1 0.2500
3 ACCIDENTAL EXPOSURE TO PRODUCT BY ELDERLY PERSON 1 0.0526
4 PROSTATIC ATROPHY 1 0.0385
5 RETINAL ARTERY STENOSIS 1 0.0278
6 DYSPLASTIC NAEVUS SYNDROME 1 0.0204
7 SEX HORMONE BINDING GLOBULIN INCREASED 1 0.0172
8 PUDENDAL CANAL SYNDROME 1 0.0132
9 BACTERIAL PROSTATITIS 1 0.0101
10 APPLICATION SITE HYPERAESTHESIA 1 0.0101
11 DERMATOPHYTOSIS OF NAIL 1 0.0084
12 PLANTAR ERYTHEMA 2 0.0081
13 MEGAKARYOCYTES INCREASED 1 0.0081
14 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 6 0.0073
15 HETEROPHORIA 1 0.0069
16 MEDICAL DEVICE SITE DISCHARGE 1 0.0065
17 CELLULITIS STREPTOCOCCAL 1 0.0063
18 TOPICAL STEROID WITHDRAWAL REACTION 2 0.0051
19 URINE ALCOHOL TEST POSITIVE 1 0.0051
20 BRONCHOALVEOLAR LAVAGE ABNORMAL 1 0.0048
21 GENITAL CANDIDIASIS 1 0.0047
22 HAEMANGIOMA OF SKIN 2 0.0046
23 EXTRAVASATION BLOOD 1 0.0042
24 ANGIOPLASTY 6 0.0040
25 PRODUCT CLOSURE ISSUE 2 0.0036
26 DERMAL ABSORPTION IMPAIRED 1 0.0036
27 POST 5-ALPHA-REDUCTASE INHIBITOR SYNDROME 1 0.0035
28 NAIL INJURY 2 0.0035
29 AVULSION FRACTURE 1 0.0035
30 APOPTOSIS 1 0.0032
31 RESPIRATORY MUSCLE WEAKNESS 1 0.0031
32 PENILE OEDEMA 1 0.0031
33 SECONDARY HYPOGONADISM 1 0.0030
34 CYSTITIS BACTERIAL 1 0.0030
35 INFLAMMATORY PAIN 2 0.0029
36 ANDROGEN DEFICIENCY 1 0.0028
37 FAECAL OCCULT BLOOD POSITIVE 1 0.0028
38 PENIS INJURY 1 0.0028
39 ALANINE AMINOTRANSFERASE DECREASED 2 0.0028
40 DIABETIC GASTROPARESIS 1 0.0027
41 ASTROCYTOMA 1 0.0025
42 NAIL PITTING 1 0.0025
43 MANUFACTURING MATERIALS ISSUE 1 0.0025
44 GENITAL INFECTION FUNGAL 2 0.0024
45 INTESTINAL PROLAPSE 1 0.0024
46 ENTEROBACTER INFECTION 4 0.0024
47 STEROID DEPENDENCE 2 0.0023
48 FUNGAL FOOT INFECTION 1 0.0023
49 POST INFLAMMATORY PIGMENTATION CHANGE 1 0.0022
50 ALLERGY TO PLANTS 1 0.0022
51 PENILE CONTUSION 1 0.0021
52 BLOOD CREATINE ABNORMAL 1 0.0021
53 ECZEMA NUMMULAR 1 0.0020
54 BLADDER MASS 1 0.0020
55 PERIORBITAL CELLULITIS 1 0.0019
56 URETHRITIS 1 0.0018
57 NAIL GROWTH ABNORMAL 2 0.0018
58 DEVICE DISLOCATION 79 0.0018
59 JUGULAR VEIN DISTENSION 1 0.0018
60 XEROPHTHALMIA 1 0.0017
61 EYE BURNS 1 0.0017
62 SPONDYLOARTHROPATHY 1 0.0017
63 MEAN PLATELET VOLUME INCREASED 1 0.0017
64 SPONTANEOUS PENILE ERECTION 1 0.0016
65 RUPTURED CEREBRAL ANEURYSM 1 0.0015
66 BRONCHITIS VIRAL 1 0.0015
67 URETHRAL STENOSIS 1 0.0015
68 HAND DERMATITIS 1 0.0014
69 GRAVITATIONAL OEDEMA 1 0.0014
70 PRODUCT EXPIRATION DATE ISSUE 2 0.0014
71 PERINEAL PAIN 1 0.0014
72 CHYLOTHORAX 1 0.0014
73 ANOSOGNOSIA 1 0.0013
74 TINEA PEDIS 2 0.0013
75 PERITONSILLAR ABSCESS 1 0.0012
76 BLOOD PROLACTIN ABNORMAL 1 0.0012
77 ALOPECIA AREATA 2 0.0011
78 INCORRECT PRODUCT FORMULATION ADMINISTERED 1 0.0011
79 DEVICE MALFUNCTION 79 0.0011
80 NUCHAL RIGIDITY 1 0.0011
81 HYPERKERATOSIS 6 0.0011
82 APPLICATION SITE DERMATITIS 1 0.0011
83 SKIN TEXTURE ABNORMAL 1 0.0010
84 EPIDERMAL NECROSIS 1 0.0010
85 SKIN OEDEMA 1 0.0010
86 SEMEN VOLUME DECREASED 1 0.0010
87 LYMPHOCYTIC INFILTRATION 1 0.0010
88 HYPOGONADISM 1 0.0010
89 TINEA INFECTION 1 0.0009
90 CORTISOL DECREASED 1 0.0009
91 DRUG LEVEL ABOVE THERAPEUTIC 4 0.0009
92 MACROCYTOSIS 1 0.0009
93 MONOCYTE COUNT DECREASED 1 0.0008
94 OTITIS EXTERNA 1 0.0008
95 XEROSIS 1 0.0008
96 MALIGNANT MELANOMA IN SITU 1 0.0008
97 ERYSIPELAS 4 0.0008
98 APPLICATION SITE WARMTH 1 0.0008
99 APPLICATION SITE EROSION 1 0.0008
100 ACTINIC KERATOSIS 2 0.0008
101 APPLICATION SITE PARAESTHESIA 1 0.0008
102 CORNEAL OPACITY 1 0.0007
103 TENDON RUPTURE 9 0.0007
104 SEBORRHOEIC KERATOSIS 1 0.0007
105 DARK CIRCLES UNDER EYES 1 0.0007
106 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
107 PREMATURE SEPARATION OF PLACENTA 1 0.0006
108 NEOPLASM SKIN 1 0.0006
109 BRONCHIAL DISORDER 1 0.0006
110 SUBSTANCE USE 1 0.0006
111 IDIOPATHIC THROMBOCYTOPENIC PURPURA 1 0.0006
112 ANTIPHOSPHOLIPID SYNDROME 1 0.0006
113 ANTICONVULSANT DRUG LEVEL INCREASED 1 0.0006
114 SEBORRHOEIC DERMATITIS 1 0.0006
115 SPLEEN DISORDER 1 0.0006
116 BLADDER NEOPLASM 1 0.0006
117 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
118 DEPRESSIVE SYMPTOM 2 0.0006
119 SKIN HYPOPIGMENTATION 1 0.0006
120 PARAPARESIS 1 0.0006
121 LUPUS NEPHRITIS 1 0.0005
122 CLEFT PALATE 1 0.0005
123 WOUND SECRETION 2 0.0005
124 PROSTATOMEGALY 2 0.0005
125 NAIL DISCOLOURATION 2 0.0005
126 SPINAL FUSION SURGERY 2 0.0005
127 PIGMENTATION DISORDER 3 0.0005
128 PHARYNGEAL ERYTHEMA 1 0.0005
129 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
130 THERAPY PARTIAL RESPONDER 7 0.0004
131 DISTURBANCE IN SOCIAL BEHAVIOUR 1 0.0004
132 PUSTULE 1 0.0004
133 GASTROINTESTINAL TOXICITY 2 0.0004
134 SLOW SPEECH 1 0.0004
135 PENIS DISORDER 1 0.0004
136 HEPATIC ENZYME ABNORMAL 2 0.0004
137 BREAST TENDERNESS 3 0.0004
138 TUBERCULIN TEST POSITIVE 1 0.0004
139 AORTIC ARTERIOSCLEROSIS 1 0.0004
140 BLOOD CHLORIDE DECREASED 1 0.0004
141 POLYARTHRITIS 2 0.0004
142 APPLICATION SITE HAEMORRHAGE 1 0.0004
143 ORAL FUNGAL INFECTION 1 0.0004
144 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
145 GRANULOCYTOPENIA 2 0.0004
146 SCAB 4 0.0004
147 HYPERTONIC BLADDER 1 0.0003
148 EYELID MARGIN CRUSTING 1 0.0003
149 DYSPNOEA AT REST 1 0.0003
150 REBOUND ACID HYPERSECRETION 1 0.0003
151 ADRENAL INSUFFICIENCY 4 0.0003
152 KERATITIS 1 0.0003
153 PROSTATITIS 1 0.0003
154 PENILE PAIN 1 0.0003
155 DYSCHEZIA 1 0.0003
156 DIASTOLIC DYSFUNCTION 1 0.0003
157 FAMILY STRESS 1 0.0003
158 SWELLING OF EYELID 2 0.0003
159 APPLICATION SITE PAIN 7 0.0003
160 TESTICULAR PAIN 1 0.0003
161 EXPOSURE TO TOXIC AGENT 1 0.0003
162 STUPOR 1 0.0003
163 APPLICATION SITE DRYNESS 1 0.0003
164 BRONCHIOLITIS 1 0.0003
165 PAPULE 2 0.0003
166 FACIAL PARESIS 1 0.0003
167 GLOSSITIS 1 0.0003
168 BREAST PAIN 3 0.0003
169 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
170 PRODUCT PRESCRIBING ISSUE 6 0.0003
171 SENSITIVE SKIN 2 0.0003
172 AMYLASE INCREASED 1 0.0003
173 TENDON INJURY 1 0.0003
174 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
175 LIPASE INCREASED 2 0.0003
176 REHABILITATION THERAPY 1 0.0003
177 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
178 SKIN ODOUR ABNORMAL 1 0.0003
179 SKIN PAPILLOMA 1 0.0002
180 MUSCLE HAEMORRHAGE 1 0.0002
181 TRIGEMINAL NEURALGIA 1 0.0002
182 GALLBLADDER OPERATION 1 0.0002
183 SOCIAL PROBLEM 1 0.0002
184 ONYCHOMADESIS 1 0.0002
185 SKIN PLAQUE 2 0.0002
186 HEPATIC CYTOLYSIS 3 0.0002
187 FEBRILE BONE MARROW APLASIA 1 0.0002
188 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
189 SKIN CANCER 5 0.0002
190 SKIN SWELLING 2 0.0002
191 MELANOCYTIC NAEVUS 1 0.0002
192 ONYCHOMYCOSIS 1 0.0002
193 IMMUNE SYSTEM DISORDER 3 0.0002
194 CATHETERISATION CARDIAC 1 0.0002
195 EAR DISORDER 1 0.0002
196 APPLICATION SITE RASH 3 0.0002
197 SKIN REACTION 3 0.0002
198 COLITIS MICROSCOPIC 1 0.0002
199 FUNGAL INFECTION 7 0.0002
200 MEDICATION RESIDUE PRESENT 1 0.0002
201 CHOLESTASIS 4 0.0002
202 TYPE 2 DIABETES MELLITUS 7 0.0002
203 APATHY 3 0.0002
204 NASAL POLYPS 1 0.0002
205 APPLICATION SITE SWELLING 1 0.0002
206 VEIN DISORDER 1 0.0002
207 COLORECTAL CANCER STAGE III 1 0.0002
208 PERIPHERAL VASCULAR DISORDER 1 0.0002
209 TEMPERATURE INTOLERANCE 2 0.0002
210 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
211 FOETAL DEATH 1 0.0002
212 PHARYNGOLARYNGEAL PAIN 1 0.0002
213 NONSPECIFIC REACTION 1 0.0002
214 PHOTOSENSITIVITY REACTION 3 0.0002
215 CHOKING SENSATION 1 0.0002
216 MACULAR OEDEMA 1 0.0002
217 PERIORBITAL SWELLING 1 0.0002
218 CARDIAC VALVE DISEASE 1 0.0002
219 SKIN ATROPHY 1 0.0002
220 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
221 METABOLIC DISORDER 1 0.0002
222 EYELID OEDEMA 2 0.0002
223 TYPE 1 DIABETES MELLITUS 1 0.0002
224 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
225 SCHIZOPHRENIA 2 0.0002
226 VULVOVAGINAL BURNING SENSATION 1 0.0002
227 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
228 MENISCUS INJURY 1 0.0002
229 CHOLANGITIS 1 0.0002
230 APPLICATION SITE IRRITATION 2 0.0002
231 MIDDLE INSOMNIA 3 0.0002
232 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
233 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1 0.0002
234 HERPES SIMPLEX 1 0.0002
235 SKIN FISSURES 3 0.0002
236 PRODUCT USE IN UNAPPROVED INDICATION 38 0.0002
237 ANHEDONIA 4 0.0002
238 PRODUCT FORMULATION ISSUE 1 0.0002
239 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
240 WRONG PRODUCT ADMINISTERED 1 0.0001
241 RASH ERYTHEMATOUS 7 0.0001
242 MATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0001
243 BLOOD TESTOSTERONE DECREASED 1 0.0001
244 INFARCTION 1 0.0001
245 ONYCHOCLASIS 1 0.0001
246 PROSTATIC SPECIFIC ANTIGEN INCREASED 2 0.0001
247 HAIR GROWTH ABNORMAL 1 0.0001
248 DERMATITIS 3 0.0001
249 RETINAL HAEMORRHAGE 1 0.0001
250 SUBDURAL HAEMATOMA 2 0.0001
251 HYPOKINESIA 2 0.0001
252 FAECES SOFT 1 0.0001
253 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
254 INFLAMMATION 7 0.0001
255 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
256 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
257 PEMPHIGOID 1 0.0001
258 HYPERTHERMIA 1 0.0001
259 ACUTE MYELOID LEUKAEMIA 2 0.0001
260 RENAL CYST 1 0.0001
261 GINGIVAL PAIN 1 0.0001
262 ATRIAL FLUTTER 1 0.0001
263 LACTIC ACIDOSIS 4 0.0001
264 MUSCLE DISORDER 1 0.0001
265 ACUTE CORONARY SYNDROME 1 0.0001
266 EXPIRED PRODUCT ADMINISTERED 4 0.0001
267 AGEUSIA 3 0.0001
268 HEMIPLEGIA 1 0.0001
269 EOSINOPHIL COUNT INCREASED 1 0.0001
270 LIVE BIRTH 1 0.0001
271 BLOOD UREA INCREASED 2 0.0001
272 DRUG USE DISORDER 1 0.0001
273 INFUSION SITE ERYTHEMA 1 0.0001
274 FACIAL PARALYSIS 1 0.0001
275 SCAR 2 0.0001
276 DRUG RESISTANCE 3 0.0001
277 PRODUCT CONTAINER ISSUE 1 0.0001
278 MUSCLE STRAIN 1 0.0001
279 CARDIAC MURMUR 1 0.0001
280 DISCOMFORT 7 0.0001
281 NAIL DISORDER 1 0.0001
282 BLOOD CALCIUM INCREASED 1 0.0001
283 LOSS OF LIBIDO 1 0.0001
284 LUPUS-LIKE SYNDROME 1 0.0001
285 LIP DRY 1 0.0001
286 RETINAL DETACHMENT 1 0.0001
287 PERSONALITY CHANGE 1 0.0001
288 AGRANULOCYTOSIS 2 0.0001
289 NEPHROPATHY 1 0.0001
290 BLISTER 6 0.0001
291 SKIN EXFOLIATION 9 0.0001
292 DRUG INEFFECTIVE 140 0.0001
293 DYSPNOEA EXERTIONAL 4 0.0001
294 SPINAL DISORDER 1 0.0001
295 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
296 HYPERCHOLESTEROLAEMIA 1 0.0001
297 VITAMIN D DEFICIENCY 1 0.0001
298 PHARYNGEAL SWELLING 1 0.0001
299 INFLAMMATORY BOWEL DISEASE 1 0.0001
300 RENAL TUBULAR NECROSIS 1 0.0001
301 LIGAMENT SPRAIN 1 0.0001
302 HAEMATOCRIT DECREASED 2 0.0001
303 CYTOKINE RELEASE SYNDROME 2 0.0001
304 VAGINAL DISCHARGE 1 0.0001
305 SKIN BURNING SENSATION 7 0.0001
306 NEUTROPHIL COUNT INCREASED 1 0.0001
307 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
308 EYE DISCHARGE 1 0.0001
309 FOLLICULITIS 1 0.0001
310 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
311 PHARYNGITIS STREPTOCOCCAL 1 0.0001
312 MENTAL DISORDER 4 0.0001
313 PSORIASIS 12 0.0001
314 PRODUCT DISPENSING ERROR 2 0.0001
315 INJECTION SITE NODULE 1 0.0001
316 FOOT DEFORMITY 1 0.0001
317 SKIN IRRITATION 4 0.0001
318 HERPES ZOSTER 5 0.0001
319 ELECTROLYTE IMBALANCE 1 0.0001
320 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
321 SEXUAL DYSFUNCTION 1 0.0001
322 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
323 ATAXIA 1 0.0001
324 BACTERAEMIA 1 0.0001
325 PRODUCT PRESCRIBING ERROR 2 0.0001
326 WRIST FRACTURE 1 0.0001
327 NOCTURIA 1 0.0001
328 INJECTION SITE URTICARIA 2 0.0001
329 DRY EYE 4 0.0001
330 MUSCLE ATROPHY 1 0.0001
331 HEPATITIS 2 0.0001
332 ERECTILE DYSFUNCTION 2 0.0001
333 SKIN ULCER 2 0.0001
334 APPLICATION SITE ERYTHEMA 2 0.0001
335 ORAL CANDIDIASIS 1 0.0001
336 DERMATITIS ATOPIC 4 0.0001
337 EYE HAEMORRHAGE 1 0.0001
338 DRY SKIN 10 0.0001
339 MALIGNANT MELANOMA 1 0.0001
340 JOINT RANGE OF MOTION DECREASED 1 0.0001
341 DISTURBANCE IN ATTENTION 4 0.0001
342 BLOOD BILIRUBIN INCREASED 2 0.0001
343 FREQUENT BOWEL MOVEMENTS 2 0.0001
344 SINUS CONGESTION 1 0.0001
345 RASH PRURITIC 4 0.0001
346 OEDEMA 4 0.0001
347 IMPAIRED GASTRIC EMPTYING 1 0.0001
348 GINGIVAL BLEEDING 1 0.0001
349 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
350 RESPIRATORY DISTRESS 2 0.0001
351 DIVERTICULITIS 2 0.0001
352 BLOOD TEST ABNORMAL 1 0.0001
353 BLINDNESS UNILATERAL 1 0.0001
354 HYPERSENSITIVITY 13 0.0001
355 RED BLOOD CELL COUNT DECREASED 2 0.0001
356 RECTAL HAEMORRHAGE 3 0.0001
357 MYELODYSPLASTIC SYNDROME 1 0.0001
358 SEPTIC SHOCK 3 0.0001
359 GASTROENTERITIS 1 0.0001
360 COVID-19 12 0.0001
361 SKIN HAEMORRHAGE 1 0.0001
362 OSTEOPENIA 1 0.0001
363 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
364 INSURANCE ISSUE 1 0.0001
365 SWELLING 6 0.0001
366 BASAL CELL CARCINOMA 1 0.0001
367 ARTHRITIS 5 0.0001
368 PRODUCT USE COMPLAINT 1 0.0001
369 DISEASE RECURRENCE 3 0.0001
370 METABOLIC ACIDOSIS 2 0.0001
371 MOVEMENT DISORDER 2 0.0001
372 CARDIAC FAILURE 5 0.0001
373 NIGHT SWEATS 2 0.0001
374 BACK DISORDER 1 0.0001
375 LUNG DISORDER 3 0.0001
376 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11 0.0001
377 MULTIPLE FRACTURES 1 0.0001
378 STAPHYLOCOCCAL INFECTION 2 0.0001
379 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
380 RASH 26 0.0001
381 PERICARDITIS 1 0.0001
382 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
383 ACUTE KIDNEY INJURY 9 0.0001
384 HEPATIC ENZYME INCREASED 4 0.0001
385 HAEMATURIA 2 0.0001
386 ERYTHEMA 12 0.0001
387 MUSCULOSKELETAL DISCOMFORT 1 0.0001
388 MYOCARDIAL INFARCTION 10 0.0001
389 BURNING SENSATION 4 0.0001
390 HYPERKALAEMIA 2 0.0001
391 ISCHAEMIC STROKE 1 0.0001
392 GALLBLADDER DISORDER 1 0.0001
393 CONDITION AGGRAVATED 17 0.0001
394 GASTROENTERITIS VIRAL 1 0.0001
395 END STAGE RENAL DISEASE 1 0.0001
396 PRURITUS 21 0.0001
397 HEPATIC STEATOSIS 1 0.0001
398 THINKING ABNORMAL 1 0.0001
399 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
400 FLATULENCE 3 0.0001
401 FOOT FRACTURE 1 0.0001
402 DYSTONIA 1 0.0001
403 EAR PAIN 1 0.0001
404 HAEMORRHOIDS 1 0.0001
405 KIDNEY INFECTION 1 0.0001
406 ABNORMAL BEHAVIOUR 2 0.0001
407 DISORIENTATION 2 0.0001
408 PROSTATE CANCER 4 0.0000
409 FULL BLOOD COUNT DECREASED 1 0.0000
410 TASTE DISORDER 1 0.0000
411 OEDEMA PERIPHERAL 6 0.0000
412 PRODUCT PREPARATION ERROR 1 0.0000
413 INTENTIONAL DRUG MISUSE 1 0.0000
414 WITHDRAWAL SYNDROME 2 0.0000
415 KNEE ARTHROPLASTY 1 0.0000
416 MOUTH ULCERATION 1 0.0000
417 IMPAIRED WORK ABILITY 1 0.0000
418 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
419 FAECES DISCOLOURED 1 0.0000
420 BLOOD CREATININE INCREASED 3 0.0000
421 FEBRILE NEUTROPENIA 3 0.0000
422 HYPOTENSION 9 0.0000
423 RASH PAPULAR 1 0.0000
424 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
425 PANCREATITIS ACUTE 1 0.0000
426 APPLICATION SITE PRURITUS 1 0.0000
427 ADVERSE EVENT 4 0.0000
428 ARRHYTHMIA 2 0.0000
429 ANAEMIA 8 0.0000
430 PRODUCTIVE COUGH 2 0.0000
431 CONTUSION 4 0.0000
432 LOCALISED INFECTION 1 0.0000
433 HOT FLUSH 3 0.0000
434 ACNE 3 0.0000
435 THERAPY CESSATION 2 0.0000
436 HAEMOGLOBIN DECREASED 4 0.0000
437 ANAPHYLACTIC SHOCK 1 0.0000
438 DECREASED APPETITE 9 0.0000
439 SEDATION 1 0.0000
440 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
441 JOINT STIFFNESS 1 0.0000
442 DEPRESSED MOOD 2 0.0000
443 EAR INFECTION 1 0.0000
444 FEAR 1 0.0000
445 PAIN OF SKIN 1 0.0000
446 CONSTIPATION 8 0.0000
447 SKIN LESION 1 0.0000
448 HAEMATOCHEZIA 2 0.0000
449 PROCEDURAL PAIN 1 0.0000
450 PANCYTOPENIA 2 0.0000
451 DEMENTIA 1 0.0000
452 EYE PAIN 2 0.0000
453 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
454 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
455 INFECTION 5 0.0000
456 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
457 PAIN IN EXTREMITY 10 0.0000
458 LABORATORY TEST ABNORMAL 1 0.0000
459 DISEASE PROGRESSION 4 0.0000
460 WHEEZING 2 0.0000
461 CATARACT 2 0.0000
462 DEVICE ISSUE 3 0.0000
463 ADVERSE DRUG REACTION 3 0.0000
464 APHASIA 1 0.0000
465 THERAPEUTIC RESPONSE DECREASED 2 0.0000
466 GYNAECOMASTIA 1 0.0000
467 LIMB DISCOMFORT 1 0.0000
468 HEAD INJURY 1 0.0000
469 HYPOTHYROIDISM 1 0.0000
470 RHINORRHOEA 2 0.0000
471 HEART RATE INCREASED 3 0.0000
472 SKIN DISORDER 1 0.0000
473 FATIGUE 23 0.0000
474 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
475 SINUSITIS 3 0.0000
476 NIGHTMARE 1 0.0000
477 RASH MACULAR 1 0.0000
478 OFF LABEL USE 25 0.0000
479 PLATELET COUNT DECREASED 3 0.0000
480 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
481 PAIN 17 0.0000
482 C-REACTIVE PROTEIN INCREASED 1 0.0000
483 DYSURIA 1 0.0000
484 BRONCHITIS 2 0.0000
485 DYSGEUSIA 2 0.0000
486 EYE SWELLING 1 0.0000
487 BLOOD GLUCOSE INCREASED 5 0.0000
488 ARTHRALGIA 11 0.0000
489 UNEVALUABLE EVENT 2 0.0000
490 MUSCULAR WEAKNESS 3 0.0000
491 CHRONIC KIDNEY DISEASE 2 0.0000
492 GAIT DISTURBANCE 5 0.0000
493 PERIPHERAL SWELLING 4 0.0000
494 ABDOMINAL PAIN 6 0.0000
495 JOINT SWELLING 3 0.0000
496 EMOTIONAL DISTRESS 3 0.0000
497 DYSPNOEA 14 0.0000
498 DRY MOUTH 2 0.0000
499 DYSKINESIA 1 0.0000
500 NEUTROPHIL COUNT DECREASED 1 0.0000
501 TREATMENT FAILURE 2 0.0000
502 RHABDOMYOLYSIS 1 0.0000
503 POLLAKIURIA 1 0.0000
504 PRODUCT DOSE OMISSION ISSUE 7 0.0000
505 RENAL FAILURE ACUTE 1 0.0000
506 URINARY TRACT INFECTION 4 0.0000
507 VAGINAL HAEMORRHAGE 1 0.0000
508 ANGIOEDEMA 1 0.0000
509 RENAL FAILURE 3 0.0000
510 INSOMNIA 6 0.0000
511 COLITIS ULCERATIVE 1 0.0000
512 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
513 THROAT IRRITATION 1 0.0000
514 DEPRESSION 5 0.0000
515 MEMORY IMPAIRMENT 3 0.0000
516 TINNITUS 1 0.0000
517 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
518 OROPHARYNGEAL PAIN 2 0.0000
519 RENAL DISORDER 1 0.0000
520 BLOOD CHOLESTEROL INCREASED 1 0.0000
521 COGNITIVE DISORDER 1 0.0000
522 COUGH 6 0.0000
523 PRODUCT USE ISSUE 4 0.0000
524 ASTHENIA 8 0.0000
525 OCULAR HYPERAEMIA 1 0.0000
526 DYSPHAGIA 2 0.0000
527 MIGRAINE 2 0.0000
528 COLORECTAL CANCER 1 0.0000
529 BLOOD GLUCOSE DECREASED 1 0.0000
530 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
531 HEADACHE 13 0.0000
532 DRUG INTOLERANCE 2 0.0000
533 PYREXIA 7 0.0000
534 DIARRHOEA 13 0.0000
535 LEUKOPENIA 1 0.0000
536 CELLULITIS 1 0.0000
537 FLUID RETENTION 1 0.0000
538 BLOOD PRESSURE INCREASED 3 0.0000
539 CHEST DISCOMFORT 2 0.0000
540 ILLNESS 2 0.0000
541 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
542 HAEMORRHAGE 2 0.0000
543 ECZEMA 1 0.0000
544 BRADYCARDIA 1 0.0000
545 DRUG EFFECT DECREASED 1 0.0000
546 TREATMENT NONCOMPLIANCE 1 0.0000
547 DEPENDENCE 1 0.0000
548 ANAPHYLACTIC REACTION 1 0.0000
549 TREMOR 3 0.0000
550 MEDICATION ERROR 1 0.0000
551 SEPSIS 2 0.0000
552 WEIGHT DECREASED 5 0.0000
553 URTICARIA 3 0.0000
554 NECK PAIN 1 0.0000
555 ABDOMINAL DISCOMFORT 3 0.0000
556 HYPONATRAEMIA 1 0.0000
557 INCORRECT DOSE ADMINISTERED 4 0.0000
558 LETHARGY 1 0.0000
559 EYE IRRITATION 1 0.0000
560 PRODUCT SUBSTITUTION ISSUE 1 0.0000
561 SEIZURE 2 0.0000
562 BONE PAIN 1 0.0000
563 SURGERY 1 0.0000
564 NASAL CONGESTION 1 0.0000
565 IRRITABILITY 1 0.0000
566 SUICIDE ATTEMPT 1 0.0000
567 STOMATITIS 1 0.0000
568 NASOPHARYNGITIS 3 0.0000
569 INJECTION SITE ERYTHEMA 2 0.0000
570 EXPOSURE DURING PREGNANCY 1 0.0000
571 BLOOD PRESSURE DECREASED 1 0.0000
572 FALL 5 0.0000
573 INJECTION SITE PRURITUS 1 0.0000
574 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
575 PRODUCT QUALITY ISSUE 2 0.0000
576 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
577 VISION BLURRED 2 0.0000
578 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
579 DIZZINESS 7 0.0000
580 THERAPY INTERRUPTED 1 0.0000
581 RESPIRATORY FAILURE 1 0.0000
582 MALAISE 6 0.0000
583 WEIGHT INCREASED 3 0.0000
584 EPISTAXIS 1 0.0000
585 HYPOAESTHESIA 2 0.0000
586 INJECTION SITE SWELLING 1 0.0000
587 INJECTION SITE BRUISING 1 0.0000
588 CARDIAC FAILURE CONGESTIVE 1 0.0000
589 CARDIAC ARREST 1 0.0000
590 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
591 CEREBROVASCULAR ACCIDENT 2 0.0000
592 PRODUCT STORAGE ERROR 1 0.0000
593 INTENTIONAL PRODUCT MISUSE 1 0.0000
594 TACHYCARDIA 1 0.0000
595 GASTROINTESTINAL DISORDER 1 0.0000
596 SUICIDAL IDEATION 1 0.0000
597 MUSCLE SPASMS 2 0.0000
598 CARDIAC DISORDER 1 0.0000
599 VOMITING 5 0.0000
600 ANXIETY 3 0.0000
601 NEUROPATHY PERIPHERAL 1 0.0000
602 ATRIAL FIBRILLATION 1 0.0000
603 SOMNOLENCE 2 0.0000
604 FLUSHING 1 0.0000
605 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
606 ABDOMINAL PAIN UPPER 2 0.0000
607 HYPERTENSION 2 0.0000
608 OVERDOSE 2 0.0000
609 THROMBOCYTOPENIA 1 0.0000
610 ASTHMA 1 0.0000
611 NAUSEA 7 0.0000
612 BACK PAIN 2 0.0000
613 CHILLS 1 0.0000
614 DEATH 7 0.0000
615 HYPERHIDROSIS 1 0.0000
616 DEHYDRATION 1 0.0000
617 NEUTROPENIA 1 0.0000
618 INJECTION SITE PAIN 2 0.0000
619 HOSPITALISATION 1 0.0000
620 DRUG INTERACTION 1 0.0000
621 CONFUSIONAL STATE 1 0.0000
622 PNEUMONIA 2 0.0000
623 TOXICITY TO VARIOUS AGENTS 1 0.0000
624 NO ADVERSE EVENT 1 0.0000
625 ALOPECIA 1 0.0000
626 FEELING ABNORMAL 1 0.0000